North America Colorectal Cancer Diagnostics Market to 2032
Overview
The North America Colorectal Cancer Diagnostics Market is expected to reach a 3.78 USD Billion by 2032 and is projected to grow at a CAGR of 12.82% from 2025 to 2032.
Revenue, 2024 (USD Billion)
1.92
Forecast, 2032 (USD Billion)
3.78
CAGR, 2024 - 2032
12.82%
Report Coverage
North America
North America Colorectal Cancer Diagnostics Market 2018-2032 USD Billion
North America Colorectal Cancer Diagnostics Market, Key Findings (2025-2032)
Market Growth and Projections:
- Market Size (2024): 1.92 USD Billion
- Projected Market Size (2032): 3.78 USD Billion
- CAGR (2025-2032): 12.82%
Key Findings of North America Colorectal Cancer Diagnostics Market
- The North America Colorectal Cancer Diagnostics Market was valued at 1.92 USD Billion in 2024.
- The North America Colorectal Cancer Diagnostics Market is likely to grow at a CAGR of 12.82% during the forecast period of 2024 to 2032.
- In 2024, the Largest segment Instruments in Product Type Segment accounted for the largest share of the market with a revenue of 1.27 USD Billion
- The fastest growing segment Hospitals in End User Segment grew Fastest with a CAGR of 16.90% during the forecast period from 2024 to 2032.
North America Colorectal Cancer Diagnostics Market Scope
North America Colorectal Cancer Diagnostics Market Segmentation & Scope
Age Group
- Pediatric
- Adults
- Geriatric
End User
- Others
- Academic Institutes
- Ambulatory Surgical Centers
- Cancer Research Centers
- Diagnostic Centers
- Hospitals
Cancer Type
- Others
- Carcinoid Tumors
- Gastrointestinal Stromal Tumors
- Colorectal Lymphoma
- Adenocarcinoma
Test Type
- Others
- Biopsy
- Tumor Markers
- Imaging Test
- Blood Test
- Stool Examination
Product Type
- Consumables & Accessories
- Instruments
Cancer Stages
- Stage 0
- Stage I
- Stage II
- Stage IV
- Stage III
North America Colorectal Cancer Diagnostics Market Data Coverage Insights
| Study Period | 2024-2032 |
| Base Year | 2021 |
| Unit | Revenue in USD Billion |
| Market Value in 2024 | 1.92 USD Billion |
| Market Value in 2032 | 3.78 USD Billion |
| CAGR (2025-2032) | 12.82% |
| Historic Data | 2016-2023 |
| Market Segments Covered | Age Group,End User,Cancer Type,Test Type,Product Type,Cancer Stages |
Regional Insights:
-
Leading Market (2024-2032): North America, leading in terms of revenue 1.92 USD Billion in 2024
- Key Country: U.S., leading in terms of revenue with value of 1,517.79 USD Million in 2024.
Segments and Scope
-
North America Colorectal Cancer Diagnostics Market to 2032, By Age Group
- Geriatric is the largest segment in North America Colorectal Cancer Diagnostics Market to 2032 with a revenue of 878.26 USD Billion in the year 2024.
- Geriatric is the Fastest growing segment in North America Colorectal Cancer Diagnostics Market to 2032 with a Growth rate of 14.43 % in forecast period 2025-2032.
-
North America Colorectal Cancer Diagnostics Market to 2032, By End User
- Hospitals is the largest segment in North America Colorectal Cancer Diagnostics Market to 2032 with a revenue of 577.44 USD Billion in the year 2024.
- Hospitals is the Fastest growing segment in North America Colorectal Cancer Diagnostics Market to 2032 with a Growth rate of 16.90 % in forecast period 2025-2032.
-
North America Colorectal Cancer Diagnostics Market to 2032, By Cancer Type
- Adenocarcinoma is the largest segment in North America Colorectal Cancer Diagnostics Market to 2032 with a revenue of 1.18 USD Billion in the year 2024.
- Adenocarcinoma is the Fastest growing segment in North America Colorectal Cancer Diagnostics Market to 2032 with a Growth rate of 14.10 % in forecast period 2025-2032.
-
North America Colorectal Cancer Diagnostics Market to 2032, By Test Type
- Stool Examination is the largest segment in North America Colorectal Cancer Diagnostics Market to 2032 with a revenue of 732.69 USD Billion in the year 2024.
- Stool Examination is the Fastest growing segment in North America Colorectal Cancer Diagnostics Market to 2032 with a Growth rate of 15.73 % in forecast period 2025-2032.
-
North America Colorectal Cancer Diagnostics Market to 2032, By Product Type
- Instruments is the largest segment in North America Colorectal Cancer Diagnostics Market to 2032 with a revenue of 1.27 USD Billion in the year 2024.
- Instruments is the Fastest growing segment in North America Colorectal Cancer Diagnostics Market to 2032 with a Growth rate of 14.36 % in forecast period 2025-2032.
-
North America Colorectal Cancer Diagnostics Market to 2032, By Cancer Stages
- Stage III is the largest segment in North America Colorectal Cancer Diagnostics Market to 2032 with a revenue of 775.40 USD Billion in the year 2024.
- Stage III is the Fastest growing segment in North America Colorectal Cancer Diagnostics Market to 2032 with a Growth rate of 16.04 % in forecast period 2025-2032.
North America Colorectal Cancer Diagnostics Market Company Share Analysis
| Company Name |
|
||
| Illumina, Inc. | |||
| Koninklijke Philips N.V. | |||
| Thermo Fisher Scientific Inc. | |||
| Quest Diagnostics Incorporated | |||
| Bio-Rad Laboratories, Inc. | |||
North America Colorectal Cancer Diagnostics Market Geographical Sales Distribution, 2018-2032 USD Billion
North America Colorectal Cancer Diagnostics Market Company Profiling
Industry Related Reports
Frequently Asked Questions
The North America Colorectal Cancer Diagnostics Market is segmented based on Segmentation Age Group,End User,Cancer Type,Test Type,Product Type,Cancer Stages.
North America Colorectal Cancer Diagnostics Market was valued at USD 1.92(Revenue in USD Billion) in 2021.
North America Colorectal Cancer Diagnostics Market is projected to grow at a CAGR of 12.82% during the forecast period of 2024 to 2032.
The Instruments segment is expected to dominate the North America Colorectal Cancer Diagnostics Market, holding a largest market share of 1.27 USD Billion in 2024
North America Colorectal Cancer Diagnostics Market Scope
North America Colorectal Cancer Diagnostics Market Segmentation & Scope
Age Group
- Pediatric
- Adults
- Geriatric
End User
- Others
- Academic Institutes
- Ambulatory Surgical Centers
- Cancer Research Centers
- Diagnostic Centers
- Hospitals
Cancer Type
- Others
- Carcinoid Tumors
- Gastrointestinal Stromal Tumors
- Colorectal Lymphoma
- Adenocarcinoma
Test Type
- Others
- Biopsy
- Tumor Markers
- Imaging Test
- Blood Test
- Stool Examination
Product Type
- Consumables & Accessories
- Instruments
Cancer Stages
- Stage 0
- Stage I
- Stage II
- Stage IV
- Stage III
Frequently Asked Questions
The North America Colorectal Cancer Diagnostics Market is segmented based on Segmentation Age Group,End User,Cancer Type,Test Type,Product Type,Cancer Stages.
North America Colorectal Cancer Diagnostics Market was valued at USD 1.92(Revenue in USD Billion) in 2021.
North America Colorectal Cancer Diagnostics Market is projected to grow at a CAGR of 12.82% during the forecast period of 2024 to 2032.
The estimated market value of the North America Colorectal Cancer Diagnostics Market for final year is USD 3.78 (USD Billion).
North America Colorectal Cancer Diagnostics Market Company Profiling
Frequently Asked Questions
The North America Colorectal Cancer Diagnostics Market is segmented based on Segmentation Age Group,End User,Cancer Type,Test Type,Product Type,Cancer Stages.
North America Colorectal Cancer Diagnostics Market was valued at USD 1.92(Revenue in USD Billion) in 2021.
North America Colorectal Cancer Diagnostics Market is projected to grow at a CAGR of 12.82% during the forecast period of 2024 to 2032.
The estimated market value of the North America Colorectal Cancer Diagnostics Market for final year is USD 3.78 (USD Billion).
CHOOSE LICENCE TYPE
- 4200.00
- 3500.00
- 2000.00
- 5500.00
- 8500.00
HAVE A QUESTION?
Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.